Cargando…

A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment

BACKGROUND: Immunotherapy is an emerging cancer therapy with potential great success; however, immune checkpoint inhibitor (e.g., anti-PD-1) has response rates of only 10–30% in solid tumor because of the immunosuppressive tumor microenvironment (TME). This affliction can be solved by vascular norma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuo, Cheng-Liang, Chou, Han-Yu, Lien, Hui-Wen, Yeh, Chia-An, Wang, Jing-Rong, Chen, Chung-Hsing, Fan, Chi-Chen, Hsu, Chih-Ping, Kao, Ting-Yu, Ko, Tai-Ming, Lee, Alan Yueh-Luen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870840/ https://www.ncbi.nlm.nih.gov/pubmed/35895109 http://dx.doi.org/10.1007/s00262-022-03255-9

Ejemplares similares

Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1
por: Mukherjee, Debayan, et al.
Publicado: (2023)

In Situ Nitric Oxide Gas Nanogenerator Reprograms Glioma Immunosuppressive Microenvironment
por: Liu, Yang, et al.
Publicado: (2023)

Ovarian endometrioma infiltrating neutrophils orchestrate immunosuppressive microenvironment
por: Xu, Hua, et al.
Publicado: (2020)

Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma
por: Terry, Rachael L., et al.
Publicado: (2021)

Immunosuppressive mechanisms of oncofetal reprogramming in the tumor microenvironment: implications in immunotherapy response
por: Currenti, Jennifer, et al.
Publicado: (2023)

Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
por: Shafqat, Areez, et al.
Publicado: (2023)

Oxygen-carrying nanoplatform to reprogram tumor immunosuppressive microenvironment and enhance photothermal-immunotherapy
por: Huang, Ju, et al.
Publicado: (2023)

Corrigendum: Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
por: Shafqat, Areez, et al.
Publicado: (2023)

Aged microglia promote peripheral T cell infiltration by reprogramming the microenvironment of neurogenic niches
por: Zhang, Xiaotao, et al.
Publicado: (2022)

Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer
por: Chen, Jing, et al.
Publicado: (2021)

Reprogramming the immunosuppressive microenvironment of IDH1 wild-type glioblastoma by blocking Wnt signaling between microglia and cancer cells
por: Fan, Dandan, et al.
Publicado: (2021)

Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?
por: Kuo, Cheng-Liang, et al.
Publicado: (2022)

Poly(ADP-ribose) polymerase 1 regulates nuclear reprogramming and promotes iPSC generation without c-Myc
por: Chiou, Shih-Hwa, et al.
Publicado: (2013)

Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment
por: Huang, Kai, et al.
Publicado: (2023)

Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression
por: Chen, Lihua, et al.
Publicado: (2022)

Exosome-Mediated Immunosuppression in Tumor Microenvironments
por: Xie, Qi-Hui, et al.
Publicado: (2022)

CTLA4-Mediated Immunosuppression in Glioblastoma is Associated with the Infiltration of Macrophages in the Tumor Microenvironment
por: Guan, Xiudong, et al.
Publicado: (2021)

Cyclin G2 reverses immunosuppressive tumor microenvironment and potentiates PD-1 blockade in glioma
por: Li, Sen, et al.
Publicado: (2021)

Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy
por: Cui, Xin, et al.
Publicado: (2020)

A time‐saving–modified Giemsa stain is a better diagnostic method of Helicobacter pylori infection compared with the rapid urease test
por: Fan, Chi‐Chen, et al.
Publicado: (2019)

Chimerism, the Microenvironment and Control of Leukemia
por: Deeg, H. Joachim
Publicado: (2021)

Immunosuppressive Microenvironment in Neuroblastoma
por: Pistoia, Vito, et al.
Publicado: (2013)

Gemcitabine treatment promotes immunosuppressive microenvironment in pancreatic tumors by supporting the infiltration, growth, and polarization of macrophages
por: Deshmukh, Sachin Kumar, et al.
Publicado: (2018)

Tumor-secreted lactate contributes to an immunosuppressive microenvironment and affects CD8 T-cell infiltration in glioblastoma
por: Wang, Zeyu, et al.
Publicado: (2023)

Metastasis and immunosuppression promoted by mtDNA and PD‐L1 in extracellular vesicles are reversed by WGP β‐glucan in oral squamous cell carcinoma
por: Ko, Hui‐Hsin, et al.
Publicado: (2023)

PD-L1-Mediated Immunosuppression in Glioblastoma Is Associated With the Infiltration and M2-Polarization of Tumor-Associated Macrophages
por: Zhu, Zhiyuan, et al.
Publicado: (2020)

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
por: Grassmann, S, et al.
Publicado: (2014)

Expression and clinical significance of PD-L1 and infiltrated immune cells in the gastric adenocarcinoma microenvironment
por: Quan, Qiuying, et al.
Publicado: (2023)

Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment
por: Kuo, I-Ying, et al.
Publicado: (2021)

Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
por: Koirala, Pratistha, et al.
Publicado: (2016)

Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1–mediated immunoescape via STING-IFN signaling and extracellular vesicles
por: Cheng, An Ning, et al.
Publicado: (2020)

Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors
por: Zhang, Xiaozhen, et al.
Publicado: (2022)

Angioimmunoblastic T-cell lymphoma with predominant CD8+ tumor-infiltrating T-cells is a distinct immune pattern with an immunosuppressive microenvironment
por: Chen, Zihang, et al.
Publicado: (2022)

Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
por: Lu, Weiqiang, et al.
Publicado: (2020)

PD-L1-Mediated Immunosuppression in Hepatocellular Carcinoma: Relationship with Macrophages Infiltration and Inflammatory Response Activity
por: Guo, Shuang, et al.
Publicado: (2022)

Mitochondrial Lon-induced mitophagy benefits hypoxic resistance via Ca(2+)-dependent FUNDC1 phosphorylation at the ER-mitochondria interface
por: Ponneri Babuharisankar, Ananth, et al.
Publicado: (2023)

Metabolic reprogramming in the immunosuppression of tumor-associated macrophages
por: Wang, Ying, et al.
Publicado: (2022)

Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment
por: Zhang, Yue, et al.
Publicado: (2023)

Modes of immunosuppression in glioblastoma microenvironment
por: Lehtipuro, Suvi, et al.
Publicado: (2019)

Role of the immunosuppressive microenvironment in immunotherapy
por: Tormoen, Garth W., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0if00tg794o52gr4jo6tauumpg